This document is page 46 of a 'Cannabis Investment Report' dated December 2017, published by Ackrell Capital, LLC. The text provides an industry overview of 'Cannabis Flower' and 'Concentrates,' discussing product types, strains (e.g., Blue Dream, OG Kush), and THC content. It appears to be part of a larger document dump collected by the House Oversight Committee (Bates stamp HOUSE_OVERSIGHT_024682), likely included in evidence files, though the specific page contains no direct references to Epstein or his associates.
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC |
Investment firm publishing the report
|
|
| Bloom Farms |
Cannabis brand featured in product image
|
|
| Headwaters |
Cannabis brand featured in product image
|
|
| FINRA |
Mentioned in footer regarding Ackrell Capital membership
|
|
| SIPC |
Mentioned in footer regarding Ackrell Capital membership
|
|
| House Oversight Committee |
Implied by Bates stamp 'HOUSE_OVERSIGHT'
|
| Location | Context |
|---|---|
|
Printed on Headwaters product box: 'Sun Grown in California'
|
"Cannabis flower, or “bud,” is the most popular product among cannabis consumers."Source
"Popular varieties today include “Blue Dream,” “Gelato,” “OG Kush,” “Pineapple Express” and “Sour Diesel.”"Source
"Due to advancements in cultivation techniques, THC levels in cannabis flower available today are generally much higher than in the past."Source
"Concentrates are quickly becoming popular for a host of reasons."Source
Complete text extracted from the document (2,436 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document